RAC-beta serine/threonine-protein kinase
| GO Term | Evidence Code | Reference |
|---|---|---|
| glycogen biosynthetic process |
|
|
| glucose metabolic process | ||
| insulin receptor signaling pathway | ||
| insulin receptor signaling pathway | ||
| insulin receptor signaling pathway |
| GO Term | Evidence Code | Reference |
|---|---|---|
| protein kinase activity | ||
| protein kinase activity | ||
| protein serine/threonine kinase activity | ||
| protein serine/threonine kinase activity | ||
| protein serine/threonine kinase activity |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 128 |
|
|
||
| 131 |
|
|
||
| 306 |
|
|
||
| 313 |
|
|
||
| 474 |
|
|
| Pathway Name | Organism |
|---|---|
| AKT phosphorylates targets in the cytosol | Mus musculus |
| AKT phosphorylates targets in the nucleus | Mus musculus |
| AKT-mediated inactivation of FOXO1A | Mus musculus |
| Activation of PKB | Mus musculus |
| CD28 dependent PI3K/Akt signaling | Mus musculus |
| Co-inhibition by CTLA4 | Mus musculus |
| Cyclin A:Cdk2-associated events at S phase entry | Mus musculus |
| Cyclin E associated events during G1/S transition | Mus musculus |
| Deactivation of the beta-catenin transactivating complex | Mus musculus |
| Downregulation of ERBB2:ERBB3 signaling | Mus musculus |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:9352 | type 2 diabetes mellitus | |
| DOID:11612 | polycystic ovary syndrome |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026